Safeguarding the health of Pennsylvania's animals, people and the ... dean, is a strong supporter of the One Health initiative and we welcome him to the team. The administration has embraced One Health, bringing Hoffman, State ...
“... On a much broader scale, the PADLS partnership and the three entities it represents—the state, and two world-class research and teaching institutions— all subscribe to the One Health interdisciplinary approach to animal, human and environmental health. Understanding and addressing the health issues created at the intersection of society, the animal world and the environment is the foundation for One Health.
I commend the leadership of retiring Dean Joan Hendricks, who fostered this approach at PennVet as dean and as a faculty member for more than 30 years. Andrew Hoffman, the new dean, is a strong supporter of the One Health initiative and we welcome him to the team.
The administration has embraced One Health, bringing Hoffman, State Veterinarian David Wolfgang, and Penn State College of Agriculture Dean Rick Roush to the table in a broader coalition that includes the departments of health, environmental protection, conservation and natural resources, and public and private sector human and veterinary health practitioners and researchers. ...”
The past, present and future of Wageningen Bioveterinary Research
Its commitment to One Health, the term given to the inter-relatedness of ... OneHealth European Joint Programme, an EU initiative aimed at aligning ...
Ferrara found he could combine his love for animals with a public-health perspective through One Health, which analyzes and addresses health ...
"...Ferrara found he could combine his love for animals with a public-health perspective through One Health [also see www.onehealthinitiative.com], which analyzes and addresses health issues at the intersections of human, animal, and environmental health. ... “The One Health perspective is inherently interdisciplinary,” ... He says he also hopes his trip to Nepal will serve as a model for future projects and sees no bounds for One Health’s potential at Penn. Eventually, Ferrara wants to establish a One Health Center on campus where students and researchers can foster ideas and develop intervention projects.” ... “It’s really about the One Health perspective,” he says. “Maybe we have our separate expertise, but One Health is a vehicle to bring people together to tackle more complex, interdisciplinary issues.” ...”
Sitting Down With… [Dr.] Richard M. Linnehan, Veterinarian/Astronaut, Houston, USA - The Pathologist, June 2018 ["...how important the concept of ONE HEALTH is..."
The Pathologist’s June issue covers what we gain from death! We speak to a team of experts behind human decomposition facilities to dig into how the dead can breathe life into research and provide vital forensic clues. We also delve into measuring the risk of Alzheimer’s disease, detecting malaria in mosquitoes with NIRS, how AI can aid healthcare, using methylation biomarkers to assist prognosis, the lab of the future, and much more. Plus, we sit down with astronaut and veterinary pathologist Richard M. Linnehan to discuss his career on and off the planet.
Sitting Down With… [Dr.] Richard M. Linnehan, Veterinarian/Astronaut, Houston, USA
“... When you look down at our planet from space, you realize that everything that seems so big and infinite… isn’t. It made me realize just how important the concept of “One Health” is. For instance, I’m a veterinarian, so I do comparative pathology – avian, reptile, amphibian, mammalian, human, even invertebrate – but most healthcare professionals focus only on humans. “One Health” brings us back to the idea that it’s all connected. Disease entities don’t stick to a single organism or environment; they move between them. The planet is smaller than we think. It’s a closed ecosystem, and everything that lives will eventually, in some way, affect everything else. ...”
June 2018
What initially prompted you to study veterinary pathology?
I was always interested in disease processes and epidemiology, but what sparked my interest in veterinary medicine was working for a local equine and large animal veterinarian in high school. I thought it was really cool that a human could actually help animals that big. I was interested in human medicine, too, but I was so intrigued by the veterinary side – especially exotic animals – that I decided to take that route.
I did my veterinary residency in comparative pathology and exotic animal medicine, and then did research and clinical work with zoo animals for several years. My main interest, even then, was in marine mammals and related ecosystems. I met the head of the US Navy’s marine mammal program while in veterinary school, and I wanted to be the program’s main veterinarian. Even though I had stayed in touch and geared my residency and extracurricular activities toward marine mammal work, I couldn’t believe it when I got the job!
The program involved training teams of sea lions and dolphins to perform underwater searches – they were much better than human divers. The animals were never in danger, of course; we just relied on them to detect and report potential hazards. In fact, they were better taken care of medically and nutritionally than most people! We also did some pretty cool research – studies on reproduction, longevity, nutrition, and many other things.
How did that lead to a career as an astronaut?
Before I applied to veterinary school, the only other thing I had ever wanted to be was a fighter pilot. I was accepted into the Air Force and veterinary school at the same time, and my advisor convinced me to choose the latter. During my studies, I used to watch the shuttle launches and ask myself, “How can I still fly?” And I figured that, if the space program was sending up mission specialists, doctors, physicists, and geologists, they’d need a veterinarian as well.
I interviewed with them (for which I can thank my experience as a deploying military marine mammal veterinarian) and, in 1992, they called me to say, “Would you like to be an astronaut?” Well – of course I would!
When you look down at our planet from space, you realize that everything that seems so big and infinite… isn’t. It made me realize just how important the concept of “One Health” is. For instance, I’m a veterinarian, so I do comparative pathology – avian, reptile, amphibian, mammalian, human, even invertebrate – but most healthcare professionals focus only on humans. “One Health” brings us back to the idea that it’s all connected. Disease entities don’t stick to a single organism or environment; they move between them. The planet is smaller than we think. It’s a closed ecosystem, and everything that lives will eventually, in some way, affect everything else.
What was your role on your missions?
My first mission, STS-78, was a life and microgravity sciences mission in the Spacelab where we looked at how various biological processes work in space. We looked at the differences in how biological systems function in zero or microgravity versus normal gravity. Everything that has ever lived on Earth has evolved in a 1 G gravity field, so when you take that away, how do things respond?
The second flight – STS-90, or Neurolab – was much more involved. We were looking at nervous system disturbances brought on by spaceflight. We had a vast array of animals – crickets, rodents, even oyster toadfish. Fish are kind of wild because their neutral buoyancy means that they live in a pseudo-microgravity environment – but they rely on gravity to tell them up from down. So how do they maintain buoyancy and navigation in space?
We also liked to joke that we had four big primates on board on whom we performed most of our experiments – us. I was pleased to have the opportunity to use my veterinary degree and pathology training to help the future survival of humanity. If we can’t figure out how to keep humans healthy and strong in space, then we’re not going to go. We won’t travel long distances to other planets, because by the time we get there, we’re going to be so unhealthy and so discombobulated that we won’t be able to function. I hope our operational studies will one day help humans take to the stars.
My final two missions were not life sciences-related, and allowed me to venture into the world of spacewalking. On STS-109, we rendezvoused with, repaired, and upgraded the Hubble Space Telescope. That was an awesome flight experience and a great mission. My last flight, STS-123, was to the International Space Station, where I and my spacewalk team helped build the space station. We installed the Japanese laboratory, called Kibo, and a giant robot called the Special Purpose Dexterous Manipulator that moves around the station and replaces worn-out parts.
What do you think is the most underrepresented aspect of pathology?
I think it’s comparative pathology – the link between disease processes in humans, animals, and the environment. We haven’t thought about it as much as we should because we’re too focused on our own species, so we don’t always consider that the same organisms and errors cause problems to other species as well, even though the presentations may be different to our own. We must remember that it’s all interrelated.
Permission to reprint granted to the One Health Initiative website July 8, 2018 by:
June 8, 2018—American Public Health Association (APHA) Organizations’ letter to U.S. Congress Appropriations Committee leaders in support of strong investments in antimicrobial resistance in FY 2019 appropriations bills using ONE HEALTH APPROACH
Saturday, July 07, 2018.
June 8, 2018—American Public Health Association (APHA) Organizations’ letter to U.S. Congress Appropriations Committee leaders in support of strong investments in antimicrobial resistance in FY 2019 appropriations bills using ONE HEALTH APPROACH
“The report also highlights the need for continued and robust funding for AMR given that nationwide testing last year documented 221 cases of so-called “nightmare bacteria,” that can spread resistance to last-resort antibiotics. Robust, sustained investment in multi-agency One Health efforts is vital to combat AMR domestically and globally including prevention, antimicrobial stewardship, surveillance and data collection, research, and development of urgently needed new products including antimicrobial drugs, diagnostics, vaccines and alternative treatments.”
11th paragraph,
“Food and Drug Administration and US Department of Agriculture Experts agree that a One Health approach, including both human and animal health, is essential for combating antimicrobial resistance. We urge funding of $54 million for the Combating Antibiotic Resistant Bacteria initiative at FDA to support FDA’s efforts to address public health concerns associated with antimicrobial drug use in animals, and better protect antibiotic effectiveness for both human and animal populations. This funding is needed now more than ever, with estimates that antibiotic use in humans and livestock will rise by 50% before 2030. FDA would be able to better collaborate with consumers, producers, veterinarians, and other agencies to monitor AMR through the National Antimicrobial Resistance Monitoring System (NARMS) as well as other initiatives by the FDA Center for Veterinary Medicine to address AMR.”
Notably, see list of prominent organizational signatories:
Accelerate Diagnostics, Inc.
AdvaMedDx
Alliance for Aging Research
Alliance for the Prudent Use of Antibiotics
American Academy of Pediatrics
American Association of Avian Pathologists
American Association of Bovine Practitioners
American Public Health Association
American Society of Transplant Surgeons
American Society of Tropical Medicine & Hygiene
American Thoracic Society
American Veterinary Medical Association
Antibiotic Resistance Action Center, the George Washington University
Antimicrobials Working Group (Amplyx Pharmaceuticals, Aridis Pharmaceuticals, Arsanis Inc., Cidara Therapeutics Inc., ContraFect Corporation, Iterum Therapeutics Ltd., Melinta Therapeutics Inc., Motif Bio plc, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., SCYNEXIS Inc., Spero Therapeutics, Inc., T2 Biosystems Inc., Theravance Biopharma U.S. Inc., Viamet, Vical Incorporated, and Zavante Therapeutics Inc.)
Association for Professionals in Infection Control and Epidemiology
Association of American Veterinary Medical Colleges
Association of State and Territorial Health Officials
Becton Dickinson and Co. (BD)
bioMerieux
Biotechnology Innovation Organization (BIO)
Center for Disease Dynamics, Economics & Policy
Center for Foodborne Illness Research and Prevention
Clinician Champions in Comprehensive Antibiotic Stewardship
Consumer Federation of America
Council of State and Territorial Epidemiologists
Da Volterra
Duke Center for Antimicrobial Stewardship and Infection Prevention
Emory Antibiotic Resistance Center
Food Animal Concerns Trust
GlaxoSmithKline
Global Health Council
Health Care Without Harm
HIV Medicine Association
Immune Deficiency Foundation
Infectious Diseases Society of America
Johns Hopkins Center for a Livable Future
Making-A-Difference in Infectious Diseases
March of Dimes
National Association of County and City Health Officials
National Association of Pediatric Nurse Practitioners
NovaDigm Therapeutics, Inc.
Pediatric Infectious Diseases Society
Peggy Lillis Foundation
Sepsis Alliance
Society of Critical Care Medicine
Society of Infectious Diseases Pharmacists
Spero Therapeutics
The Fecal Transplant Foundation
The Gerontological Society of America
The Pew Charitable Trusts
The Society for Healthcare Epidemiology of America
The Society of Critical Care Medicine
Treatment Action Group
Trust for America's Health
Guidelines for Inspection of Companion and Commercial Animal Establishments
Friday, July 06, 2018.
Guidelines for Inspection of Companion and Commercial Animal Establishments
“Various establishments exist in which animals are held for a variety of reasons. Historically, the management and inspection of animals in commerce and in private keeping have involved a considerable degree of arbitrary evaluation based on the personal experience of the vendor, keeper, advisor, or inspector. Accordingly, relevant protocols and standards are subject to considerable variation. Relatedly, diversity of traded and privately kept species generates significant challenges for those responsible for facility management and inspection alike. Animal welfare and public health and safety are constant and major concerns that require objective methodologies to monitor and control. This report focuses on establishments concerned with the boarding, breeding, storage, vending or handover of animals intended for human “companions” or “pets”, and aims to provide universal objective information for essential husbandry, inspection protocols and an allied inspection assessment tool for scoring establishments.”
Citation: Warwick C, Jessop M, Arena P, Pilny A and Steedman C (2018) Guidelines for Inspection of Companion and Commercial Animal Establishments. Front. Vet. Sci. 5:151. doi: 10.3389/fvets.2018.00151
Using a One Health Approach, Duke Researchers and Collaborators in China Find Evidence for Cross-species Influenza A Transmission Within Swine Farms By Laura Borkenhagen, MSc
In an effort to better understand the influenza A virus transmission between humans and pigs, Duke University researchers and collaborators from multiple organizations in China conducted a large prospective study of pigs, pig workers, and six pig farms. Their important work is one of the few to be conducted interdisciplinary way. It was recently published in the high impact journal Clinical Infectious Diseases.
Duke One Health Mongolian Team Identifies Potential Risk Factors for Zoonotic Disease Transmission Among Horse and Camel Herder Households
By Lexi Sack, DVM
In this pilot study, One Health D43 team 2 researchers from Duke University and The Institute of Veterinary Medicine in Mongolia conducted a survey of 131 households to determine the risk factors for transmitting zoonotic disease in households caring for horses and camels. Public health concerns may arise from using dried manure for fuel and drinking unprocessed river water.
Duke and University of Iowa Experts Point Out Novel Pathogen Threats Emerging from Chinese Swine Farms By Jane Fieldhouse, MSc
In the high impact journal Lancet Infectious Diseases, Professor Gregory Gray from Duke University and Professor & former dean James Merchant from the University of Iowa College of Public Health commented upon emerging pathogens threats from China’s growing swine industry. They argue that heightened biosafety and biosecurity measures are immediately needed to prevent future novel pathogen outbreaks.
Two Duke Global Health Institute Rising Second-Year Master’s Students Conduct Fieldwork Research in Borneo Island of Malaysia for 10 Weeks
Juliana Zemke is conducting a surveillance of arboviruses in Sarawak, Malaysia. Arbovirus surveillance is vastly under-resourced, relying heavily on passive surveillance systems in Malaysia. The current diagnostic methods for patients presenting with dengue-like infections may misconstrue cases of dengue, chikungunya, and Zika virus infections, given that all three arboviruses have similar clinical manifestations. In this pilot study, Juliana aims to gather evidence to determine the prevalence of dengue, chikungunya, and Zika viruses among patients with dengue-like infections at Sibu and Kapit hospitals. She also plans to validate the clinical value of the T-Cor 8 Real-Time PCR Thermocycler (Tetracore Inc., USA) in detecting these viruses.
Jessica Choi is conducting a field trail of new diagnostics help the local physicians and laboratorians in Kapit more rapidly diagnose a dangerous bacterial disease, melioidosis. The current diagnostics are limited by the time and inaccuracy. For melioidosis patients, the administration of antibiotics is critical as the bacteria causing melioidosis, Burkholderia pseudomallei, may lead to fatal conditions if left untreated. The rapid diagnostic tool developed by the University of Nevada team, which uses lateral flow immunoassay, may be a promising solution for the Kapit communities. This is the first time that this novel tool is being validated in a melioidosis-epidemic site. Jessica hopes that the new diagnostics will provide a better care for the affected individuals and that the Kapit medical team will build confidence when facing the future melioidosis patients.